Anti-CD120a/TNFRSF1A Polyclonal Antibody: A Powerful Tool for Targeting Inflammation and Autoimmune Diseases
Introduction:
The Anti-CD120a/TNFRSF1A Polyclonal Antibody is a highly specific and effective tool for studying inflammation and autoimmune diseases. This versatile antibody targets the CD120a/TNFRSF1A receptor, a key player in the inflammatory response, and has been extensively validated for use in a variety of experimental applications.
Biological Function:
CD120a/TNFRSF1A is a cell surface receptor that belongs to the tumor necrosis factor (TNF) receptor superfamily. It is primarily expressed on immune cells and plays a crucial role in the regulation of inflammation and immune response. Upon binding to its ligand, TNF-alpha, CD120a/TNFRSF1A triggers a cascade of signaling events that lead to the activation of various inflammatory pathways. This makes it a promising target for the treatment of inflammatory and autoimmune diseases.
Main Applications:
The Anti-CD120a/TNFRSF1A Polyclonal Antibody is a valuable tool for researchers studying inflammation and autoimmune diseases. It can be used in a wide range of applications, including Western blotting, immunohistochemistry, flow cytometry, and immunoprecipitation. This antibody has been shown to specifically recognize CD120a/TNFRSF1A in a variety of cell types and species, making it a reliable choice for diverse research needs.
Experimental Use Cases:
The Anti-CD120a/TNFRSF1A Polyclonal Antibody has been successfully used in numerous studies to investigate the role of CD120a/TNFRSF1A in various inflammatory and autoimmune conditions. For example, it has been used to study the involvement of CD120a/TNFRSF1A in rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. In addition, this antibody has been used to assess the efficacy of potential therapeutic agents targeting CD120a/TNFRSF1A.
Conclusion:
In summary, the Anti-CD120a/TNFRSF1A Polyclonal Antibody is a highly specific and reliable tool for studying inflammation and autoimmune diseases. Its ability to target the CD120a/TNFRSF1A receptor and its versatility in a variety of experimental applications make it an essential component of any research focused on these areas. With its proven effectiveness and extensive validation, this antibody is a valuable addition to any laboratory investigating the complex mechanisms of inflammation and autoimmunity.
Keywords: Anti-CD120a/TNFRSF1A Polyclonal Antibody, inflammation, autoimmune diseases, CD120a/TNFRSF1A receptor, TNF-alpha, Western blotting, immunohistochemistry, flow cytometry, immunoprecipitation, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, therapeutic agents, research.
There are no reviews yet.